Capital Research Global Investors Grows Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Capital Research Global Investors lifted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 1.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 25,362,352 shares of the company’s stock after purchasing an additional 389,796 shares during the quarter. Capital Research Global Investors owned about 0.06% of GE HealthCare Technologies worth $2,080,248,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of GEHC. Laurel Wealth Advisors LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $26,000. Optima Capital LLC purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Godfrey Financial Associates Inc. purchased a new position in shares of GE HealthCare Technologies in the 4th quarter valued at approximately $27,000. Montag A & Associates Inc. raised its position in shares of GE HealthCare Technologies by 105.4% in the 4th quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock valued at $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Maseco LLP acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth $29,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Stock Performance

GEHC opened at $64.67 on Friday. GE HealthCare Technologies Inc. has a 12-month low of $58.75 and a 12-month high of $89.77. The company has a current ratio of 1.22, a quick ratio of 0.95 and a debt-to-equity ratio of 0.95. The firm has a market capitalization of $29.42 billion, a PE ratio of 15.47, a P/E/G ratio of 1.46 and a beta of 0.74. The firm has a 50 day moving average of $66.89 and a two-hundred day moving average of $75.49.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The business had revenue of $5.13 billion for the quarter, compared to analysts’ expectations of $5.04 billion. During the same period in the prior year, the business posted $1.01 earnings per share. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, analysts anticipate that GE HealthCare Technologies Inc. will post 4.89 EPS for the current year.

Wall Street Analyst Weigh In

A number of brokerages have recently weighed in on GEHC. JPMorgan Chase & Co. dropped their price objective on shares of GE HealthCare Technologies from $80.00 to $65.00 and set a “neutral” rating on the stock in a report on Thursday, April 30th. Barclays dropped their price objective on shares of GE HealthCare Technologies from $87.00 to $78.00 and set an “equal weight” rating on the stock in a report on Thursday, April 30th. Argus dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $80.00 and set a “buy” rating on the stock in a report on Tuesday, May 19th. Jefferies Financial Group dropped their price objective on shares of GE HealthCare Technologies from $105.00 to $90.00 in a report on Thursday, April 30th. Finally, BNP Paribas Exane dropped their price objective on shares of GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Nine analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $80.21.

Insider Activity at GE HealthCare Technologies

In other GE HealthCare Technologies news, CEO Peter J. Arduini purchased 4,169 shares of GE HealthCare Technologies stock in a transaction on Thursday, April 30th. The stock was bought at an average cost of $59.92 per share, with a total value of $249,806.48. Following the transaction, the chief executive officer owned 259,424 shares of the company’s stock, valued at $15,544,686.08. This represents a 1.63% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Kevin Lobo purchased 10,000 shares of GE HealthCare Technologies stock in a transaction on Friday, May 22nd. The shares were acquired at an average cost of $64.18 per share, with a total value of $641,800.00. Following the completion of the transaction, the director directly owned 14,363 shares in the company, valued at $921,817.34. The trade was a 229.20% increase in their position. The SEC filing for this purchase provides additional information. Insiders bought a total of 21,847 shares of company stock worth $1,361,355 in the last ninety days. 0.36% of the stock is owned by company insiders.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.